Prepare for your visit
Moshe Levy
Pediatrics · Manalapan, NJ · NPI 1205860889
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$7,569.95
in general payments reported to CMS, 2019-2025 · $5,861 in 2025
The $5,861 reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $6,499.33
- Genzyme Corporation $328.92
- Baxter Healthcare $200.00
- Supernus Pharmaceuticals, INC. $153.16
- Kaleo, INC. $76.24
- Takeda Pharmaceuticals U.S.A., INC. $41.81
Drugs and devices associated with these payments
Epkinly Hillrom - Spot Vision Screener Cerezyme Qelbree Fabrazyme Immunocap Ojjaara Iclusig Vpriv Jaypirca Verzenio Retevmo
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Moshe Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/100460/moshe-levy